Skip Navigation
  • The MHH
  • International office
  • Emergency numbers
  • Patients & Visitors
  • Facilities & Departments
    • Facilities & Departments
    • MHH Clinical departments
    • MHH-Institutes
    • Clinical departments and institutes sorted by center
    • Interdisciplinary centers
    • Central facilities
  • Research
    • Research
    • Research foci
      • Research foci
      • COVID-19
    • Core Research Units
      • Core Research Units
      • MeDIC
      • Hannover Unified Biobank (HUB)
      • Lasermikroskopie
      • Research Core Unit Electron Microscopy
    • Academic Career Development
    • Advisory Services
      • Advisory Services
      • DFG
    • Research Infrastructure
    • Dean of Research
    • Good Scientific Practice
      • Good Scientific Practice
      • Commission for Good Scientific Practice
      • Ombuds Office and Ombudsperson
    • Transparency in Research
    • Research Funding, Knowledge & Technology Transfer
      • Research Funding, Knowledge & Technology Transfer
      • Partners & Networks
      • For life scientists
      • For partners & investors
      • For startups and founders
  • Studying at MHH
    • Studying at MHH
    • All degree programs
    • Registrar's Office
      • Registrar's Office
      • Prospective students
      • Students
      • Dates & deadlines
      • Contact
  • Careers
    • Careers
    • MTR - Our diagnostics specialists with insight
Welcome to the MHH News
Searched for lachmann. Found 7 results in 5 Millisekunden.

Filter by:

  • All content
  • Common content
  • Ambulances
  • News
News

More safety for medicines

Relevance: 100%
 

homepage www.RESIST-cluster.de. SERVICE: For further information, please contact Professor Dr Nico Lachmann, Lachmann.Nico@mh-hannover.de , telephone (0511) 532-5366. [...] safety assessment of drugs. "The iPYRO method will revolutionise drug safety" Professor Dr Nico Lachmann, Department of Paediatric Pneumology, Allergology and Neonatology at the Hannover Medical School [...] parenterally by injection - i.e. all injection solutions, infusions as well as vaccines," says Professor Lachmann. An "ERC Proof of Concept Grant" is intended to explore the commercial or societal innovation potential

News

Using immune cells to develop new active substances and improve the efficacy and safety of drugs

Relevance: 93%
 

cell preparations are playing an increasingly important role in modern medicine. Professor Dr. Nico Lachmann, research group leader at the Clinic for Paediatric Pneumology, Allergology and Neonatology at Hannover [...] "This is a major problem for the health industry and massively slows down innovation," Professor Lachmann points out. In order to meet the steadily growing demand, biomedical research is therefore trying [...] Based on this key technology for the continuous production of macrophages from iPSC, Professor Lachmann's team also wants to develop new manufacturing processes for different fully standardised immune

News

Cells of the future

Relevance: 86%
 

ambitious goal of scientists at Hannover Medical School (MHH). With this in mind, Professor Dr. Nico Lachmann and Dr. Robert Zweigerdt have initiated a research collaboration and license agreement with the [...] far, there has been no clinical application of iPS cell progenies in Germany," explains Professor Lachmann. Macrophages as a therapeutic agent for bacterial lung infections In pre-clinical proof-of-concept [...] pleased that we can now advance this idea towards real therapies," says Dr. Zweigerdt. Professor Lachmann holds a professorship funded by the Cluster of Excellence RESIST and conducts research at the MHH

News

Research for the weakest

Relevance: 79%
 

MHH Institute of Virology is investigating how the virus multiplies in the cell. Professor Dr Nico Lachmann's work also revolves around pneumonia: he is researching certain immune cells that can eliminate [...] can be cured with the help of phagocytes grown from human stem cells in the laboratory. Professor Lachmann works in the MHH Clinic for Paediatric Pneumology, Allergology and Neonatology. We now know from

News

MHH awards 105 doctorates and two doctoral prizes

Relevance: 68%
 

Restores the Cellular Phenotype of Autosomal Recessive CompleteIFN-γR1 Deficiency" with Professor Nico Lachmann, MD, MHH Department of Pediatric Pneumology, Allergology and Neonatology. As part of the experimental [...] treat this disease, which is called autosomal recessive complete IFN-γR1 deficiency. In Professor Lachmann's research group, gene shuttles were successfully developed, which were tested for their function

News

MHH Trains U.S. Students in Cell and Tissue Biomanufacturing

Relevance: 65%
 

principal investigator at MHH along with co-investigators Dr. Ina Gruh , Dr. Ruth Olmer , Dr. Nico Lachmann and Dr. Stefan Kalies . In total, the project will bring 15 visiting student researchers from Auburn

News

Clever minds are given freedom to innovate

Relevance: 60%
 

tissues and organs, such as stem cell-based therapies and gene therapies," describes Professor Dr Nico Lachmann. The researcher at the MHH Clinic for Paediatric Pneumology, Allergology and Neonatology and holder

Imprint Intranet Contact Privacy Accessibility
The MHH Hospital is a maximum care hospital with a nationwide catchment area. The university teaches medicine, dentistry, biochemistry, biomedicine, midwifery and health sciences. The main research areas are Transplantation and Stem Cell Research / Regenerative Medicine, Infection and Immunology Research, Biomedical Engineering and Implant Research.

   

Information about

Blood donation service MHH-Alumni e.V.

Follow us on

Facebook Instagram YouTube Xing LinkedIn
© 2019 - 2025 Medizinische Hochschule Hannover
Nach oben scrollen